Cipla & Pharma Stocks Surge on US Drug Price News

  Published 10 months ago

Cipla shares are rising, mirroring gains in the pharma sector, fueled by reports the US has exempted generic drugs from planned price cuts. This news from Reuters is boosting investor confidence.

  • Cipla stock is trading higher today.
  • US exempts generics from price cuts.
  • Positive outlook for pharma companies.

You might like these

Force Motors Q1 PBT Surges 53%

Google's AI Search Overhaul: Traffic & Future

Kharif Crop Area Update 2025

JPMorgan Lifts Syrma SGS Target to ₹950

RBI Rate Cut Weakens Rupee Amid FX Pressures

RBI Holds Repo Rate at 5.5%

Paytm Q1 Profit Hits ₹123 Cr

News that matters the most ⚡